openPR Logo
Press release

Neuroprotection Market Emerging Technologies, Growing Opportunity and Adoption of Innovative Trends Offerings to New Investment Opportunities | F. Hoffmann-La Roche AG, Eli Lilly and Company, Novartis AG

01-24-2025 08:13 AM CET | Health & Medicine

Press release from: DataM Intelligence 4 Market Research LLP

Neuroprotection Market

Neuroprotection Market

Neuroprotection Market is expected to grow at a CAGR of 8.2% during the forecast period 2024-2031

Neuroprotection Market analysis, according to DataM Intelligence, offers more than just an overview, it investigates the underlying aspects of the sector. The study provides an overview, the research explores the hidden aspects of the sector, breaking down its intricate dynamics, charting regional dominance, spotting demand patterns, and spotting prospective breakthroughs that could influence how businesses operate in the future.

Get a Free Sample PDF copy of the report - https://datamintelligence.com/download-sample/neuroprotection-market

The Neuroprotection market report majorly focuses on market trends, historical growth rates, technologies, and the changing investment structure. Additionally, the report shows the latest market insights, increasing growth opportunities, business strategies, and growth plans adopted by major players. Moreover, it contains an analysis of current market dynamics, future developments, and Porter's Five Forces Analysis.

Neuroprotection refers to strategies or interventions aimed at preserving the structure and function of neurons (nerve cells) in the brain and nervous system, particularly in the context of injury or disease. The goal of neuroprotection is to prevent or reduce neuronal damage and degeneration caused by various conditions such as stroke, traumatic brain injury, neurodegenerative diseases (e.g., Alzheimer's, Parkinson's), and spinal cord injuries. Neuroprotective therapies may involve the use of drugs, lifestyle changes, or medical devices that minimize inflammation, oxidative stress, or excitotoxicity (excessive stimulation of neurons). The field of neuroprotection is a key area of research focused on developing treatments to safeguard brain health and improve the outcomes for individuals with neurological disorders.

Forecast Growth Projected:

The Global Neuroprotection Market is anticipated to rise at a considerable rate during the forecast period, between 2024 and 2031. In 2023, the market is growing at a steady rate, and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.

List of the Key Players in the Neuroprotection Market:

F. Hoffmann-La Roche AG, Eli Lilly and Company, Novartis AG, AstraZeneca, Teva Pharmaceutical Industries Ltd., Biogen, Astrocyte Pharmaceuticals, Inc., AbbVie Inc., Medtronic, Merck KGaA

Transform Your Strategy with Expert Market Analysis: https://www.datamintelligence.com/competitive-intelligence

Segment Covered in the Neuroprotection Market:

By Product: Anti-inflammatory Agents, Antioxidants, Anti-apoptotic, Anti-excitotoxic, Pro-mitochondrial

By Application: Prevention, Treatment

๐ˆ๐ง๐๐ฎ๐ฌ๐ญ๐ซ๐ฒ ๐ƒ๐ž๐ฏ๐ž๐ฅ๐จ๐ฉ๐ฆ๐ž๐ง๐ญ:

๐๐ž๐ฎ๐ซ๐จ๐•๐ข๐ฏ๐ž'๐ฌ ๐๐•๐๐ŸŽ๐Ÿ๐Ÿ“
Launched in late 2024, NVP015 targets mitochondrial dysfunction, a key factor in neurodegenerative diseases like Parkinson's and Alzheimer's. Early trials show promise in improving mitochondrial function and slowing disease progression.

๐‚๐ž๐ซ๐ž๐ ๐ž๐ง๐ž'๐ฌ ๐‚๐„๐‘๐„-๐Ÿ๐Ÿ๐ŸŽIntroduced in January 2025, CERE-120 is a gene therapy that delivers neurotrophic factors to the brain, aiming to enhance neuroprotection for Parkinson's disease patients and potentially slow its progression.

๐†๐ž๐ง๐ž๐ซ๐ฏ๐จ๐ง'๐ฌ ๐†๐Œ๐Ÿ”๐ŸŽ๐Ÿ’
Launched in December 2024, GM604 is an investigational drug for neurodegenerative diseases like ALS. Early studies suggest it may improve motor function and slow disease progression, offering hope for ALS treatment.

Get this Premium Report: https://www.datamintelligence.com/buy-now-page?report=neuroprotection-market

Regional Break out:

The global Neuroprotection Market report focuses on six major regions: North America, South America, Europe, Asia Pacific, the Middle East, and Africa.

โ˜ž North America - US, Canada, Mexico

โ˜ž Europe- Germany, Russia, UK, France, Italy, Rest of Europe

โ˜ž Asia Pacific- China, India, Japan, Australia, Rest of Asia Pacific

โ˜ž South America- Brazil, Argentina, Colombia, Rest of South America

โ˜ž Middle East and Africa- Saudi Arabia, UAE, Oman, Bahrain, Qatar, Kuwait, Israel

Chapter Outline:

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: key insights, key emerging trends, etc.

Chapter 3: Manufacturers competitive analysis, detailed analysis of Neuroprotection manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.

Chapter 5 & 6: Revenue of Neuroprotection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: The main points and conclusions of the report.

Speak to Our Senior Analyst and Get Customization in the report as per your requirements: https://datamintelligence.com/customize/neuroprotection-market

Frequently asked questions:

โž  What is the global sales value, production value, consumption value, import and export of Neuroprotection market?

โž  Who are the global key manufacturers of the Neuroprotection Industry? How is their operating situation (capacity, production, sales, price, cost, gross, and revenue)?

โž  What are the Neuroprotection market opportunities and threats faced by the vendors in the global Neuroprotection Industry?

โž  Which application/end-user or product type may seek incremental growth prospects? What is the market share of each type and application?

โž  What focused approach and constraints are holding the Neuroprotection market?

โž  What are the different sales, marketing, and distribution channels in the global industry?

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Neuroprotection Market Emerging Technologies, Growing Opportunity and Adoption of Innovative Trends Offerings to New Investment Opportunities | F. Hoffmann-La Roche AG, Eli Lilly and Company, Novartis AG here

News-ID: 3831512 • Views: โ€ฆ

More Releases from DataM Intelligence 4 Market Research LLP

Antioxidants Market Is Booming By Vita Foods 2026: Top Companies - Kaneka Medical Europe N.V., International Flavors & Fragrances Inc., ADM, Kemin Industries, Inc
Antioxidants Market Is Booming By Vita Foods 2026: Top Companies - Kaneka Medica โ€ฆ
DataM Intelligence has published a new research report on "Antioxidants Market Size 2025". The report explores comprehensive and insightful Information about various key factors like Regional Growth, Segmentation, CAGR, Business Revenue Status of Top Key Players and Drivers. The purpose of this report is to provide a telescopic view of the current market size by value and volume, opportunities, and development status. Antioxidants Market Size reached US$ 5.34 billion in 2024โ€ฆ
Global Krill for Pet Food Market Trends & Industry Insights 2025 | Major Companies - Aker BioMarine, Rimfrost AS, Kessler Zoologiewholesale GmbH & Co. KG
Global Krill for Pet Food Market Trends & Industry Insights 2025 | Major Compani โ€ฆ
Global Krill for Pet Food Market reached US$ 410.2 million in 2022 and is expected to reach US$ 1,001.2 million by 2031, growing with a CAGR of 11.8% during the forecast period 2024-2031. The Krill for Pet Food Market receives exhaustive analysis from DataM Intelligence, delivering stakeholders essential market data, emerging industry patterns, and strategic business intelligence. This in-depth research explores the competitive landscape in detail, evaluating market leaders across multipleโ€ฆ
Herbal Supplements Market 2025: Global Trends, Opportunities & Vita Foods 2026 - Industry Leaders are IVC Europe Healthcare, Archer Daniels Midland Company
Herbal Supplements Market 2025: Global Trends, Opportunities & Vita Foods 2026 - โ€ฆ
DataM Intelligence has published a new research report on "Herbal Supplements Market Size 2025". The report explores comprehensive and insightful Information about various key factors like Regional Growth, Segmentation, CAGR, Business Revenue Status of Top Key Players and Drivers. The purpose of this report is to provide a telescopic view of the current market size by value and volume, opportunities, and development status. Get a Sample PDF Of This Report (Getโ€ฆ
Future of Animal Parasiticides Market: Sustainable and Effective Parasite Control Solutions | Major Companies - Zoetis Services LLC., Elanco, Virbac, Boehringer Ingelheim International GmbH.
Future of Animal Parasiticides Market: Sustainable and Effective Parasite Contro โ€ฆ
Global Animal Parasiticides market reached US$ 11.8 billion in 2022 and is expected to reach US$ 19.09 billion by 2031, growing with a CAGR of 6.2% during the forecast period 2024-2031. The Animal Parasiticides Market receives exhaustive analysis from DataM Intelligence, delivering stakeholders essential market data, emerging industry patterns, and strategic business intelligence. This in-depth research explores the competitive landscape in detail, evaluating market leaders across multiple dimensions including their innovativeโ€ฆ

All 5 Releases


More Releases for Neuroprotection

Breakthrough in Neuroprotection: Nooglutil Shows Promise in Preclinical Studies
A novel neuroprotective agent, Nooglutil [https://www.biofingredients.com/biof-supply-nooglutil-cas-112193-35-8-n-5-hydroxy-3-pyridinylcarbonyl-l-glutamic-acid-product/], has emerged as a promising candidate for treating neurodegenerative disorders, according to recent preclinical research. Developed to address unmet medical needs in Alzheimer's disease (AD), Parkinson's disease (PD), and stroke recovery, Nooglutil combines two active components-nopracitabine and gyltio clone-to enhance neuronal resilience and cognitive function through dual mechanisms. Mechanism and Preclinical Efficacy Nopracitabine, a natural neurotransmitter precursor, promotes acetylcholine synthesis, critical for memory and learning .โ€ฆ
Neuroprotection: A Guide to Understanding the Process
Neuroprotection is involvement capable to affect the etiology or the pathogenesis of the neurodegenerative diseases. They delay the onset or the development of neurodegenerative diseases. Neuroprotective products are medications that protect the brain neurons from deterioration and injury. Get More Details with Sample PDF Copy @ https://www.theinsightpartners.com/sample/TIPMD00002291/?utm_source=OpenPR&utm_medium=10129 These products are used in the cure of several central nervous system complications such as Alzheimer's disease, Parkinson's disease and traumatic brain injuriesโ€ฆ
Empowering Neuroprotection: Market Growth Projections & Trends 2024-2031
Report Overview Neuroprotection Market is expected to grow at a CAGR of 8.2% during the forecast period 2024-2031 Neuroprotection refers to the capacity to promote recovery, salvage, and regeneration of the nervous system's structure, cells, and functions. It involves the prevention of neuronal cell death by inhibiting pathogenic cascades that lead to cellular dysfunction. Various neurochemical modulators can cause damage to the nervous system, highlighting the importance of therapeuticโ€ฆ
Neuroprotective Agents Market - Empowering Neuroprotection for Optimal Brain Fun โ€ฆ
Newark, New Castle, USA: The "Neuroprotective Agents Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors. Neuroprotective Agents Market: https://www.growthplusreports.com/report/neuroprotective-agents-market/8412 This latest report researches the industry structure, sales, revenue,โ€ฆ
Neuroprotection Market Share, Sales Channels and Overview Till 2028
Neuroprotection is involvement capable to affect the etiology or the pathogenesis of the neurodegenerative diseases. They delay the onset or the development of neurodegenerative diseases. Neuroprotective products are medications that protect the brain neurons from deterioration and injury. These products are used in the cure of several central nervous system complications such as Alzheimer's disease, Parkinson's disease and traumatic brain injuries among others. Neuroprotective agents in clinical pipelines comprise small-moleculeโ€ฆ
Global Neuroprotection Market Research
The Global Neuroprotection Market Research Global Neuroprotection Market Research neuroprotection showcase was esteemed at roughly US$ 47,000.0 Mn in 2016 is anticipated to enroll a development rate of 8.2% from 2017 to 2025, as per another report distributed by Transparency Market Research (TMR) titled "Neuroprotection Market โ€“ Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2017โ€“ 2025". The Global Neuroprotection Market Research report proposes that expanding occurrence and predominanceโ€ฆ